³í¹®) Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial ¼¼ºê¶õ½ºº´¿ø ½ÉÀå³»°ú È«¸í±â·±èº´±Ø·È«¼ºÁø ±³¼ö¿Í Â÷Àǰú´ëÇÐ Àå¾ç¼ö ±³¼ö ¿¬±¸ÆÀ